Skip to main content Back to Top
Advertisement

10/17/2019

Ranitidine Injection

Products Affected - Description

    • Zantac solution for injection, Teligent, 25 mg/mL, 2 mL vial, 1 count, NDC 52565-0101-10
    • Zantac solution for injection, Teligent, 25 mg/mL, 40 mL vial, 1 count, NDC 52565-0096-01
    • Zantac solution for injection, Teligent, 25 mg/mL, 6 mL vial, 1 count, NDC 52565-0102-01
    • Ranitidine solution for injection, Zydus, 25 mg/mL, 2 mL vial, 10 count, NDC 68382-0422-02
    • Ranitidine solution for injection, Zydus, 25 mg/mL, 40 mL bulk vial, 1 count, NDC 70710-1550-01
    • Ranitidine solution for injection, Zydus, 25 mg/mL, 6 mL vial, 1 count, NDC 68382-0423-06

Reason for the Shortage

    • Mylan has ranitidine injection available.
    • Teligent has Zantac IV on shortage due to production delays.
    • Zydus has ranitidine injection on shortage because the product is undergoing additional testing to ensure patient safety.

Available Products

    • Ranitidine solution for injection, Mylan Institutional, 25 mg/mL, 2 mL vial, 10 count, NDC 67457-0397-99
    • Ranitidine solution for injection, Mylan Institutional, 25 mg/mL, 6 mL vial, 1 count, NDC 67457-0398-62

Estimated Resupply Dates

    • Zydus has ranitidine 25 mg/mL 2 mL, 6 mL, and 40 mL vials on back order and the company cannot estimate a release date.
    • Teligent has all Zantac injection presentations on back order and the company estimates a release date of late-1st quarter 2020.

Updated

Updated October 17, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. Created May 16, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins